|
NOP56 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.163700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.604510E-03 |
| Normal-vs-Stage2 |
1.258390E-01 |
| Normal-vs-Stage3 |
6.953300E-04 |
| Normal-vs-Stage4 |
7.60030000046541E-07 |
| Stage1-vs-Stage2 |
5.696800E-01 |
| Stage1-vs-Stage3 |
4.678000E-01 |
| Stage1-vs-Stage4 |
1.403930E-02 |
| Stage2-vs-Stage3 |
3.583000E-01 |
| Stage2-vs-Stage4 |
3.464200E-02 |
| Stage3-vs-Stage4 |
7.881600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.079890E-03 |
| Normal-vs-AfricanAmerican |
1.029760E-02 |
| Normal-vs-Asian |
2.170800E-01 |
| Caucasian-vs-AfricanAmerican |
7.809000E-01 |
| Caucasian-vs-Asian |
8.812400E-02 |
| AfricanAmerican-vs-Asian |
1.484760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.165410E-04 |
| Normal-vs-Female |
1.661570E-03 |
| Male-vs-Female |
2.771600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.779600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.162500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.097820E-03 |
| Normal-vs-Age(81-100Yrs) |
2.890400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.085600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.561600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.448600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.517800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.983400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.762800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.112800E-01 |
| Classical-VS-Follicular |
4.414800E-01 |
| Classical-VS-Other |
5.296800E-01 |
| Classical-VS-Normal |
1.064170E-03 |
| Tall-VS-Follicular |
4.941600E-01 |
| Tall-VS-Other |
9.061000E-01 |
| Tall-VS-Normal |
4.400500E-04 |
| Follicular-VS-Other |
6.913800E-01 |
| Follicular-VS-Normal |
3.819700E-03 |
| Other-VS-Normal |
1.711650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.779300E-03 |
| Normal-vs-N1 |
1.12860000001103E-06 |
| N0-vs-N1 |
5.816500E-03 |
|
|
